<DOC>
	<DOC>NCT00908934</DOC>
	<brief_summary>The aims of this study are to compare the blood levels achieved with a new formulation of AZD9056 to an existing formulation of AZD9056 used in previous studies.</brief_summary>
	<brief_title>AZD9056 Relative Bioavailability Study</brief_title>
	<detailed_description />
	<criteria>Provision of informed consent prior to any studyspecific procedures Healthy Volunteers, Females should not be of childbearing potential BMI between 18 and 30 kg/m2 Clinically significant ECG abnormality suggestive of underlying cardiovascular disease A history or presence of GI, hepatic or renal disease or other condition known to interfere with the absorption, distribution, metabolism and excretion of drugs Known or suspected drug or alcohol abuse or positive DOA test</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Relative Bioavailability</keyword>
	<keyword>AZD9056</keyword>
</DOC>